Lectenz® Bio receives NIH SBIR Phase II

Lectenz® Bio receives NIH SBIR Phase II

The National Institute of General Medical Sciences (NIGMS) awards Lectenz® Bio an SBIR Phase II to further develop sialic acid Lectenz®.